These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34930607)

  • 1. Prognostic Impact of Ground-Glass Opacity/Lepidic Component in Pulmonary Adenocarcinoma: A Hazy Staging Dilemma.
    Joubert P; Travis WD
    J Thorac Oncol; 2022 Jan; 17(1):19-21. PubMed ID: 34930607
    [No Abstract]   [Full Text] [Related]  

  • 2. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
    Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
    Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Ground-Glass Opacities in the Lung Cancer Spectrum.
    Zhang Y; Fu F; Chen H
    Ann Thorac Surg; 2020 Dec; 110(6):1796-1804. PubMed ID: 32525031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
    Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
    Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.
    Zhou J; Li Y; Zhang Y; Liu G; Tan H; Hu Y; Xiao J; Shi H
    Oncotarget; 2017 Apr; 8(14):23312-23321. PubMed ID: 28423576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASO Author Reflections: Impact of Ground-Glass Opacity Components in Long-Term Survivors with Resected Lung Adenocarcinoma.
    Shigefuku S; Shimada Y
    Ann Surg Oncol; 2021 Jan; 28(1):157-158. PubMed ID: 33067744
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
    Wang Y; Jing L; Wang G
    J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma.
    Hattori A; Hirayama S; Matsunaga T; Hayashi T; Takamochi K; Oh S; Suzuki K
    J Thorac Oncol; 2019 Feb; 14(2):265-275. PubMed ID: 30368010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The correlation study of ground glass opacity and lepidic growth pattern component in stage I lung invasive adenocarcinoma].
    Zhang L; Wu N; Li M; Sun W; Lyu L; Hou DH; Lin DM
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):269-273. PubMed ID: 28550666
    [No Abstract]   [Full Text] [Related]  

  • 10. New T1 classification.
    Lin PMF; Hsin MK
    Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):665-671. PubMed ID: 31679135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRCT features between lepidic-predominant type and other pathological subtypes in early-stage invasive pulmonary adenocarcinoma appearing as a ground-glass nodule.
    Zhang P; Li T; Tao X; Jin X; Zhao S
    BMC Cancer; 2021 Oct; 21(1):1124. PubMed ID: 34666705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does ground glass opacity-dominant feature have a prognostic significance even in clinical T2aN0M0 lung adenocarcinoma?
    Nakamura S; Fukui T; Kawaguchi K; Fukumoto K; Hirakawa A; Yokoi K
    Lung Cancer; 2015 Jul; 89(1):38-42. PubMed ID: 25963638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings.
    Tsutani Y; Miyata Y; Yamanaka T; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):17-23. PubMed ID: 23246051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The maximum standardized uptake value of preoperative positron emission tomography/computed tomography in lung adenocarcinoma with a ground-glass opacity component of less than 30 mm.
    Son BY; Cho S; Yum SW; Kim K; Jheon S
    J Surg Oncol; 2018 Mar; 117(3):451-456. PubMed ID: 29127699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma.
    Sun F; Huang Y; Yang X; Zhan C; Xi J; Lin Z; Shi Y; Jiang W; Wang Q
    Cancer Imaging; 2020 Dec; 20(1):87. PubMed ID: 33308323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications.
    Kim EA; Johkoh T; Lee KS; Han J; Fujimoto K; Sadohara J; Yang PS; Kozuka T; Honda O; Kim S
    AJR Am J Roentgenol; 2001 Dec; 177(6):1417-22. PubMed ID: 11717098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan.
    Suzuki K; Asamura H; Kusumoto M; Kondo H; Tsuchiya R
    Ann Thorac Surg; 2002 Nov; 74(5):1635-9. PubMed ID: 12440622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
    Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
    Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiquantitative Computed Tomography Characteristics for Lung Adenocarcinoma and Their Association With Lung Cancer Survival.
    Wang H; Schabath MB; Liu Y; Berglund AE; Bloom GC; Kim J; Stringfield O; Eikman EA; Klippenstein DL; Heine JJ; Eschrich SA; Ye Z; Gillies RJ
    Clin Lung Cancer; 2015 Nov; 16(6):e141-63. PubMed ID: 26077095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Aokage K; Saji H; Watanabe SI;
    J Thorac Cardiovasc Surg; 2021 Apr; 161(4):1469-1480. PubMed ID: 32451073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.